top of page
< Back

First MDR-certified SkyWalk delivered to Rehaklinik Tschugg

The first MDR-certified SkyWalk has been delivered to Rehaklinik Tschugg, marking the start of its clinical use in Europe.

Fabian Bischof

Following MDR certification, the gait support and fall protection system is now available in Europe.


On October 29, 2026, Rehaklinik Tschugg received Europe’s first Skywalk. The handover marks the first delivery to a European clinic of the newly MDR-certified system developed by Swiss MedTech company autonomyo.


The European Medical Device Regulation, or MDR, defines the safety, performance, clinical evaluation and quality requirements that medical devices must meet before being placed on the European market.


From clinical testing to daily therapy

Rehaklinik Tschugg already had practical experience with Skywalk. The system was tested at the clinic under real clinical conditions in early 2026, providing valuable feedback for its further development.

The physiotherapy team particularly valued the reliable harness support, the minimal arm effort required and the flexibility offered by the system. Patient feedback was also very positive, especially regarding their personal sense of safety.


With the official handover, Skywalk has now returned to the clinic where it was tested in direct collaboration with therapists and patients.


Greater safety and freedom when walking

Skywalk is designed for people with mobility limitations caused by neurological conditions. Its dynamic body-weight support and fall protection system helps patients practise standing and walking safely and repeatedly.

Unlike conventional walking aids, Skywalk focuses on the walking movement itself. Patients are secured by a harness while their arms remain largely free. This creates new possibilities for balance exercises, gait training and therapy for people who are afraid of falling.

Its mobile design allows training to extend beyond a fixed therapy station. Exercises can take place in the therapy room and in a range of everyday situations, from walking on different surfaces to taking part in activities.


“With Europe’s first Skywalk, we can offer our patients safe gait training that reflects everyday life, whether indoors, sometimes with a ball, or outdoors overlooking Lake Biel. This promotes safety and motivation and creates new possibilities in therapy.”

Annina Anliker, Head of Physiotherapy, Rehaklinik Tschugg


Celebrating a shared milestone

The delivery is the result of close collaboration between Rehaklinik Tschugg and autonomyo. Insights from the clinical testing phase helped shape the system’s further development and prepare it for therapeutic use.

Skywalk is already FDA-certified and has been delivered to customers in the United States. Its certification under the European Medical Device Regulation now enables its introduction to the European market.


“Following FDA certification and the first deliveries in the United States, MDR certification is another major milestone for autonomyo. Rehaklinik Tschugg tested the Skywalk early on under real clinical conditions and provided us with valuable feedback. We are all the more delighted that Europe’s first Skywalk is now being used in Tschugg.”

René Trost, CEO, autonomyo Sàrl

Asset 1@6x.png

Blake Scribner, VP Marketing 

​(001) 925-209-1490

blake.scribner@autonomyo.com

325 Sentry Parkway,
Building 5 West, Suite 200
Blue Bell, PA 19422

​

Etoy / Lausanne

Switzerland

©2026 Autonomyo USA LLC. All Rights Reserved

Subscribe to our Newsletter

Thanks for signing-up!

bottom of page